Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Completed 2Withdrawn 1Enrolling by invitation 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Leukemia, Myeloid, Acute 115Myelodysplastic Syndromes 109Precursor Cell Lymphoblastic Leukemia-Lymphoma 95Leukemia 74Hodgkin Disease 73Leukemia, Lymphocytic, Chronic, B-Cell 72Multiple Myeloma 71Lymphoma, Non-Hodgkin 71Lymphoma 66Myeloproliferative Disorders 54Graft vs Host Disease 50Lymphoma, Follicular 49Lymphoma, Mantle-Cell 47Leukemia, Myeloid, Accelerated Phase 47Lymphoma, Large B-Cell, Diffuse 46Congenital Abnormalities 46Leukemia, Myelomonocytic, Chronic 44Lymphoma, B-Cell, Marginal Zone 43Hematologic Neoplasms 43Leukemia, Myelogenous, Chronic, BCR-ABL Positive 42Leukemia, Myeloid, Chronic-Phase 41Burkitt Lymphoma 40Primary Myelofibrosis 39Blast Crisis 38Neoplasms, Plasma Cell 37Lymphoma, Large-Cell, Immunoblastic 32Waldenstrom Macroglobulinemia 25Myelodysplastic-Myeloproliferative Diseases 24Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 24Lymphoma, T-Cell, Cutaneous 23

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Tacrolimus × Clear all
NCT02081755 2026-01-27

Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

Baylor Research Institute

Phase 4 Enrolling by invitation
336 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02702960 2018-06-15

Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Carcinoma, Hepatocellular

NCT01374750 2016-06-01

Sirolimus

Seoul National University Hospital

Phase 2 Completed
45 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00355862 2014-07-30

Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

University of Regensburg

Phase 3 Completed
525 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡